Conjugated linoleic Acid supplementation does not reduce visceral adipose tissue in middle-aged men engaged in a resistance-training program

Roger E Adams, Andie Hsueh, Betty Alford, Clay King, Huanbiao Mo, Robert Wildman, Roger E Adams, Andie Hsueh, Betty Alford, Clay King, Huanbiao Mo, Robert Wildman

Abstract

Conjugated linoleic acid (CLA) supplementation has shown convincing effects at reducing body fat in animals; yet human study results have been somewhat inconclusive. The purpose of this study is to determine whether four weeks of CLA supplementation, the approximate length of a commercial package, can result in a positive change in visceral adipose tissue in resistance-trained middle-aged men. Thirty overweight and moderately obese, but otherwise healthy male subjects (aged 35 to 55 years) currently involved in resistance training, were randomly assigned into CLA and placebo groups in a double-blind, placebo controlled approach. The study lasted for 12 weeks and consisted of three four-week periods. During the first four weeks (run-in period) each subject received placebo (4 g safflower oil). Throughout the next four weeks (supplementation period), the placebo group continued receiving placebo, while the CLA group received 3.2 g/d of CLA. During the final four weeks (run-out period) all subjects received the placebo. Computed tomography (CT) scans were used to measure visceral adipose tissue (VAT) at weeks 4, 8 and 12. No significant reduction in VAT cross-sectional area was determined in the CLA group during the study. On the contrary, a significant reduction in cross-sectional area of VAT of 23.12 cm2 during the supplementation period was measured in the placebo group, which was abated during the run-out period. Our results suggest that CLA supplementation of 3.2 g/d for four weeks does not promote decreases in VAT in middle-aged men currently participating in a resistance-training program.

Figures

Figure 1
Figure 1
Block diagram of CLA study timeline throughout 12 weeks of study. FFQ = Food Frequency Questionnaire.
Figure 2
Figure 2
A sample of a typical CT scan. AW = abdominal wall; SAT = subcutaneous adipose tissue; VAT = visceral adipose tissue.

References

    1. Pariza MW, Park Y, Cook ME. The biologically active isomers of conjugated linoleic acid. Progress in Lipid Research. 2001;40:283–298. doi: 10.1016/S0163-7827(01)00008-X.
    1. Pariza MW, Park Y, Cook ME. Mechanisms of action of conjugated linoleic acid: evidence and speculation. Proc Soc Exp Biol Med. 2000;223:8–13. doi: 10.1046/j.1525-1373.2000.22302.x.
    1. Pariza MW, Hargraves WA. A beef-derived mutagenesis modulator inhibits initiation of mouse epidermal tumors by 7.12-dimethylbenz[a]anthracene. Carcinogenesis. 1985;6:591–593. doi: 10.1093/carcin/6.4.591.
    1. Lee KN, Kritchevsky D, Pariza MW. Conjugated linoleic acid and atherosclerosis in rabbits. Atherosclerosis. 1994;108:19–25. doi: 10.1016/0021-9150(94)90034-5.
    1. Cook ME, Miller CC, Park Y, Pariza MW. Immune modulation by altered nutrient metabolism: Nutritional control of immune-induced growth depression. Poultry Sci. 1993;72:1301–1305.
    1. Miller CC, Park Y, Pariza MW, et al. Feeding conjugated linoleic acid to animals partially overcomes catabolic responses due to endotoxin injection. Biochem Biophys Res Commun. 1994;198:1107–1112. doi: 10.1006/bbrc.1994.1157.
    1. Park Y, Storkson JM, Albright KJ, et al. Evidence that the trans-10, cis-12 isomer of conjugated linoleic acid induces body composition changes in mice. Lipids. 1999;34:235–241. doi: 10.1007/s11745-999-0358-8.
    1. Chin SF, Storkson JM, Albright KJ, et al. Conjugated linoleic acid is a growth factor for rats as shown by enhanced weight gain and improved feed efficiency. J Nutr. 1994;124:2344–2349.
    1. Park Y, Albright KJ, Storkson JM, et al. Changes in body composition in mice during feeding and withdrawal of conjugated linoleic acid. Lipids. 1999;34:243–248. doi: 10.1007/s11745-999-0359-7.
    1. Azain MJ, Hausman DB, Sisk MB, et al. Dietary conjugated linoleic acid reduces rat adipose tissue cell size rather than cell number. J Nutr. 2000;130:1548–1554.
    1. West DB, Delany JP, Camet PM, et al. Effects of conjugated linoleic acid on body fat and energy metabolism in the mouse. Am J Physiol. 1998;275:R667–R672.
    1. Park Y, Albright KJ, Liu W, et al. Effect of conjugated linoleic acid on body composition in mice. Lipids. 1997;32:853–858. doi: 10.1007/s11745-997-0109-x.
    1. DeLany JP, Blohm F, Truett AA, et al. Conjugated linoleic acid rapidly reduces body fat content in mice without affecting energy intake. Am J Physiol. 1999;276:R1172–R1179.
    1. Blankson H, Stakkestad JA, Fagertun H, et al. Conjugated linoleic acid reduces body fat mass in overweight and obese humans. J Nutr. 2000;130:2943–2948.
    1. Smedman A, Vessby B. Conjugated linoleic acid supplementation in humans – metabolic effects. Lipids. 2001;36:773–781. doi: 10.1007/s11745-001-0784-7.
    1. Risérus U, Berglund L, Vessby B. Conjugated linoleic acid (CLA) reduced abdominal adipose tissue in obese middle-aged men with signs of the metabolic syndrome: a randomised controlled trial. Int J Obes Relat Metab Disord. 2001;25:1129–1135. doi: 10.1038/sj.ijo.0801659.
    1. Kreider RB, Ferreira MP, Greenwood M, et al. Effects of conjugated linoleic acid supplementation during resistance training on body composition, bone density, strength, and selected hematological markers. J Strength Cond Res. 2002;16:325–334. doi: 10.1519/1533-4287(2002)016<0325:EOCLAS>;2.
    1. Eyjolfson V, Spriet LL, Dyck DJ. Conjugated linoleic acid improves insulin sensitively in young, sedentary humans. Med Sci Sports Exerc. 2004;36:814–820. doi: 10.1249/01.MSS.0000126391.42896.31.
    1. Berven G, Bye A, Hals H, et al. Safety of conjugated linoleic acid (CLA) in overweight or obese human volunteers. Eur J Lipid Sci Technol. 2000;102:455–462. doi: 10.1002/1438-9312(200008)102:7<455::AID-EJLT455>;2-V.
    1. Zambell KL, Keim NL, Van Loan MD, et al. Conjugated linoleic acid supplementation in humans: effects on body composition and energy expenditure. Lipids. 2000;35:777–782. doi: 10.1007/s11745-000-0585-z.
    1. Malpuech-Brugère C, Verboeket-van de Venne WPHG, et al. Effects of two conjugated linoleic acid isomers on body fat mass in overweight humans. Obes Res. 2003;12:591–598.
    1. Lowery LM, Appicelli PA, Lemon PWR. Conjugated linoleic acid enhances muscle size and strength gains in novice bodybuilders. Med Sci Sports Exerc. 1998;30:S182.
    1. Kamphuis MM, Lejeune MP, Saris WH, Westerterp-Plantenga MS. The effect of conjugated linoleic acid supplementation after weight loss on body weight regain, body composition, and resting metabolic rate in overweight subjects. Int J Obes Relat Metab Disord. 2003;27:840–847. doi: 10.1038/sj.ijo.0802304.
    1. Kamphuis MM, Lejeune MP, Saris WH, Westerterp-Plantenga MS. Effect of conjugated linoleic acid supplementation after weight loss on appetite and food intake in overweight subjects. Eur J Clin Nutr. 2003;57:1268–1274. doi: 10.1038/sj.ejcn.1601684.
    1. Atkinson RL. Conjugated linoleic acid for altering body composition and treating obesity. In: Yurawecz MP, Mossoba MM, Kramer JKG, et al, editor. Advances in Conjugated Linoleic Acid Research. Vol. 1. American Oil Chemists' Society Press Champaign, IL; 1999. pp. 328–353.
    1. Rexrode KM, Buring JE, Manson JE. Abdominal and total adiposity and risk of coronary heart disease in men. Int J Obes Relat Metab Disord. 2001;25:1047–1056. doi: 10.1038/sj.ijo.0801615.
    1. Sjöström L, Kvist H, Cederblad A, Tylén U. Determination of total adipose tissue and body fat in women by computed tomography, 40K, and tritium. Am J Physiol. 1986;250:E736–E745.
    1. Kvist H, Chowdbury B, Sjöström L, et al. Adipose tissue volume determination in males by computed tomography and 40K. Int J Obes. 1988;12:249–266.
    1. Shen W, Punyanitya M, Wang Z, et al. Visceral adipose tissue: relations between single-slice areas and total volume. Am J Clin Nutr. 2004;80:271–278.
    1. Thom E, Wadstein J, Gudmundsen O. Conjugated linoleic acid reduces body fat in healthy exercising humans. J Int Med Res. 2001;29:392–396.
    1. Mougios V, Matsakas A, Petridou A, et al. Effect of supplementation with conjugated linoleic acid on human serum lipids and body fat. J Nutr Biochem. 2001;12:585–594. doi: 10.1016/S0955-2863(01)00177-2.
    1. Erselcan T, Candan F, Saruhan S, Ayca T. Comparison of body composition analysis methods in clinical routine. Ann Nutr Metab. 2000;44:243–248. doi: 10.1159/000046691.
    1. Risérus U, Arner P, Brismar K, Vessby B. Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. Diabetes Care. 2002;25:1516–1521. doi: 10.2337/diacare.25.9.1516.
    1. Gaullier JM, Halse J, Hoye K, et al. Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans. Am J Clin Nutr. 2004;79:1118–1125.
    1. Kvist H, Hallgren P, Jonsson L, et al. Distribution of adipose tissue and muscle mass in alcoholic men. Metabolism. 1993;42:569–573. doi: 10.1016/0026-0495(93)90214-9.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel